FIELD: medicine, pharmaceutics.
SUBSTANCE: given invention refers to pharmaceutics and medicine and concerns the use of compounds of formula (I) their pharmaceutically acceptable salts and solvates for treating depression and related disorders, Parkinson's disease, drug addiction, morphine tolerance and morphine dependence.
EFFECT: development of the preparation for treating depression and related disorders, Parkinson's disease, drug addiction, morphine tolerance and morphine dependence.
7 cl, 5 tbl, 33 ex
Title | Year | Author | Number |
---|---|---|---|
QUINOLINE AND QUINAZOLINE DERIVATIVES WITH AFFINITY TO 5HT-RECEPTORS | 2004 |
|
RU2402533C2 |
CONDENSED TRICYCLIC DERIVATIVES FOR TREATING PSYCHOTIC DISORDERS | 2005 |
|
RU2409582C2 |
SPIRO CONDENSED PYRROLIDINE DERIVATIVES AS INHIBITORS OF DEUBIQUITINATING ENZYMES (DUB) | 2017 |
|
RU2730552C2 |
CATECHOL-O-METHYL TRANSFERASE INHIBITORS AND USE THEREOF IN TREATING PSYCHOTIC DISORDERS | 2011 |
|
RU2586974C2 |
NOVEL COMPOUNDS | 2016 |
|
RU2734256C2 |
PHENOXYPYRIDINYLAMIDE DERIVATIVES, AND THEIR USE IN TREATMENT OF PDE4-MEDIATED DISEASE STATES | 2009 |
|
RU2509077C2 |
QUINOLINE CARBOXAMIDE AND QUINOLINE CARBONITRILE DERIVATIVES AS mGluR2 NEGATIVE ALLOSTERIC MODULATORS, COMPOSITIONS AND USE THEREOF | 2012 |
|
RU2610262C2 |
GLYCINE DERIVATIVES AND THEIR USE AS MUSCARINIC RECEPTOR ANTAGONISTS | 2011 |
|
RU2585767C2 |
INDOLE AND BENZOMORPHOLINE DERIVATIVES AS MODULATOR OF METABOTROPIC GLUTAMATE RECEPTORS | 2009 |
|
RU2517181C2 |
ALKYL SULPHONAMIDE QUINOLINES WITH AFFINITY TO NK-3 RECEPTORS | 2006 |
|
RU2421447C2 |
Authors
Dates
2013-01-20—Published
2008-06-20—Filed